A major new insight into how Hepatitis B virus works could pave the way for new drug treatments for the infection, which is the major cause of liver cancer worldwide.
The team at the Universities of York and Leeds identified an “assembly code” in the genetic material of Hepatitis B virus that allows it to create a protective casing in which it can produce new infectious virus particles.
They found that the signal, generated by ribonucleic acid (RNA), helps viral proteins to overcome an ‘engineering problem’, assembling them into in a particular geometric pattern.
Molecular machine
Professor Reidun Twarock, mathematical biologist at the University of York’s Department of Mathematics and Biology, said: “It is a bit like the chain on a bicycle. If we don’t assemble the chain on the sprockets, it becomes tangled and won’t function. Once assembled correctly, it connects the pedals with the wheels allowing the component parts to work together.
“We see the same process happening between the Hepatitis B RNA signals and the viral proteins. The proteins are attracted by these signals, which then promote their assembly into a precise molecular machine that allows the virus to produce a DNA copy of its genetic material and hence become infectious.”
The virus is transmitted through blood and bodily fluids. It is thought that more than two billion people have been infected worldwide, and around 350 million people remain carriers of the infection, which can, over time, result in their deaths.
Potential drug
The virus occurs in Europe but is much more common in parts of Asia, especially China and Africa. There are more than one million infected people in the USA where treatments can include expensive drugs and even liver transplantation.
Professor Peter Stockley, a structural virologist from the University of Leeds Astbury Centre, said: “There is a vaccine for the virus, but once you have the condition there is no treatment, other than drugs that can reduce symptoms but not change the long-term outlook.
“We often compare the disease to HIV due to the way in which the virus is passed from person-to-person, but unlike HIV there are no effective drugs to improve quality of life outcomes. Now that we know how the virus assembles, we can interrupt the interactions with the RNA signals – a bit like when a twig catches the sprocket on a bike, knocking the chain off.”
Learn more: Scientists step closer to drug treatment for Hepatitis B
The Latest on: Hepatitis B
[google_news title=”” keyword=”Hepatitis B” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
- Altimmune Axes Hepatitis B Program After Phase II Failure, Focuses on Obesity and MASHon March 28, 2024 at 9:13 am
Altimmune on Wednesday said it is ending development of HepTcell, a hepatitis B candidate, following disappointing trial results as it focuses on obesity and metabolic dysfunction-associated ...
- KDHE still monitoring hepatitis A outbreak in Shawnee Co.on March 27, 2024 at 12:55 pm
The local health department is working with state officials to track a highly contagious disease. KSNT 27 News checked in with the Kansas Department of Health and Environment ...
- Altimmune bails on hepatitis B after phase 2 data disappoint, quashing partnering planson March 27, 2024 at 12:57 am
Altimmune has been beaten by hepatitis B. The drug candidate, which the company was preparing for partnering, failed to meet the bar for further development in a phase 2 study, prompting the biotech ...
- Precision Biosciences files patent for engineered meganuclease for treating hepatitis B virus infectionson March 26, 2024 at 5:33 am
Discover Precision Biosciences' groundbreaking patent for engineered meganucleases targeting Hepatitis B virus, offering improved characteristics for treating infections and hepatocellular carcinoma.
- Is Hepatitis Contagious?on March 26, 2024 at 4:22 am
Hepatitis is swelling or inflammation of the liver, often caused by a viral infection. In the United States, the most common types of viral hepatitis are hepatitis A, B, and C. Hepatitis D and E are ...
- Illness To Wellness: Fighting Hepatitis B With More Vigouron March 23, 2024 at 8:44 am
Mumbai: To curb mother-to-child transmission of viral hepatitis, the Institute of Liver and Biliary Sciences (ILBS) along with ‘Illness To Wellness’, a corporate social responsibility (CSR) programme, ...
- Illness To Wellness, ILBS collaborate to spread awareness, end discrimination against viral hepatitison March 23, 2024 at 4:09 am
Hepatitis B infects over 40 million people in India, and most patients continue to suffer as society largely remains weighed down by misconceptions related to the disease.
- Study explains why Hepatitis B vaccine uptake is dismally low in Indiaon March 23, 2024 at 12:56 am
New Delhi, March 22 (IANS) Despite the availability of an effective vaccine against the Hepatitis B virus for over 30 years, its uptake has been low in India due to poor knowledge and lack of ...
- ‘Illness To Wellness’ joins hands with ILBS to generate awareness, end discrimination against Hepatitis B patientson March 22, 2024 at 8:19 pm
Hepatitis B infects over 40 million people in India and most patients continue to suffer as the society largely remains weighed down by misconceptions related to the disease.
- How Serious Is Hepatitis A? A Review By Doctorson March 21, 2024 at 2:28 pm
Expert opinion from Saria Mahveen Shareef MBBS, PGDCC, Spl Cardiology · 6 years of experience · India Hepatitis is caused by the hepatitis A virus. It can sometimes lead to fulminant hepatic failure ...
via Google News and Bing News